Navigation Links
American Regent Resumes Shipment of Injectable Products
Date:5/6/2011

SHIRLEY, N.Y., May 6, 2011 /PRNewswire/ -- American Regent announced today that it had resumed the shipment of its multisource injectable products on May 5, 2011.  Release of products is being prioritized and American Regent is working closely with the FDA Drug Shortage Staff to ensure that supplies of critically needed medications are available for patient care.

Please Note: Products have been shipped and are available from your local Wholesaler or Distributor.

In addition to Venofer® (iron sucrose injection, USP), the following products have been released and shipped:Atropine Sulfate Injection, USPCaffeine Citrate Injection, USPChromic Chloride Injection, USPConcentrated Zinc Sulfate Injection, USPDehydrated Alcohol Injection, USPDopamine HCL Injection, USPDroperidol Injection, USPGlycopyrrolate Injection, USPHydroxyzine HCL Injection, USPIron Dextran Injection, USP (Dexferrum®)L-Cysteine HCL Injection, USPMultitrace® -4 (Trace Elements Injection 4, USP)Multitrace® -4 Concentrate (Trace Elements Injection 4, USP - Concentrate)Multitrace® -5 Concentrate (Trace Elements Injection 5, USP - Concentrate)Neostigmine Methylsulfate Injection, USP  Nitroglycerin Injection, USPPapaverine HCL Injection, USPPhenylephrine HCL Injection, USPPotassium Phosphates Injection, USPSodium Phosphates Injection, USPAmerican Regent can confirm that these products were manufactured in accordance with cGMP and quality requirements and that they meet all USP and other internal monograph and quality release specifications. American Regent is confident in the integrity and quality of these injectable products.

Visit our website at www.americanregent.com for daily updates on product releases and availability or contact our Customer Service Department at: 1-800-645-1706. We apologize for any inconvenience this temporary suspension of manufacturing and distribution has caused. We appreciate the tremendous support that our customers and partners have given us during this period and for your continued loyalty and confidence in our products.

American Regent will continue to work diligently to research, develop and supply quality injectable products, as it has done since 1967.

If you have any questions or need to place an order for an emergency "drop shipment" please contact our Customer Service Department at 1-800-645-1706 or for more information, please visit our website at: www.americanregent.com


'/>"/>

SOURCE American Regent, Inc. & Luitpold Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. American Regent Initiates Nationwide Voluntary Recall of Caffeine & Sodium Benzoate Injection, USP 250 mg/mL, 2 mL Single Dose Vial Due to Visible Particulates
2. American Pacific to Release Financial Results and Hold Fiscal 2011 Second Quarter Investor Teleconference
3. American Medical Systems GreenLight HPS® Approved for Use in Japan
4. Christiana Care Breast Center First in Delaware to Earn American College of Radiology Accreditation
5. Plato BioPharma Presenting Poster at the American Thoracic Society Conference
6. Hologic Features New Minimally Invasive Technologies at the American Congress of Obstetricians and Gynecologists Annual Meeting
7. Reportlinker Adds Latin American Markets for Dental Implants, Final Abutments and Computer Guided Surgery 2011 (Argentina, Brazil and Mexico)
8. American Regent Resumes Shipment of VENOFER® (iron sucrose injection, USP)
9. May is Older Americans Month
10. Nonin Medical Announces Mark VanderWerf, Vice President-eHealth, Elected to American Telemedicine Association College of Fellows
11. Pearl Therapeutics to Present Complete PT003 Results from Phase 2b COPD Study in a Late-Breaker Session at the American Thoracic Society Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/26/2016)... ... 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic ... World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. ... some of the world’s leading providers of cereal and other breakfast foods. Its residents ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
Breaking Medicine News(10 mins):